Citi is out with its report today on SunOpta STKL, maintaining Buy.
In a note to clients, Citi writes, "We believe n-t rev momentum combined w/solid positioning heading into ‘11 should result in solid stock outperformance. STKL trades at 15x C11 EPS vs. the natural food group at 26x, yet STKL should be able to achieve similar growth. If the company is able to deliver in-line results over the next several Qs, we think there could continue to be nice stock upside potential
over the next 12 months."
Citi maintains an $11 PT on STKL.
At the time of posting, shares of STKL were trading at $7.22, down 0.14% from Tuesday's close.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.